Jun 19, 2024
PharmaForce International: Benchmarking Report Captures Key U.S. Immunology Companies' Strategic Responses to the 2023 Biosimilar Approvals
Aug 04, 2020
PharmaForce International: MSL Engagement Tactics for Leading US Pharmaceutical Companies Continue to Change Dramatically
Jun 18, 2020
PharmaForce International: United States Oncology Market Sees a Shift in 2020 Commercial Approaches
Dec 24, 2019
PharmaForce International: Unique Sales Force Trends in the EU5 Biosimilar Market
May 23, 2019
2019 Competitive Benchmarking of Leading Oncology Organizations: Commercialization Trends That are Shaping the U.S. Solid and Liquid Tumor Marketplaces
Dec 06, 2018
Sales Force Deployment for Diabetes Products has Migrated Toward a Multi-Therapeutic Approach in Japan, According to PharmaForce International
Nov 27, 2018
Research Indicates Higher Advantages in the Functions of Thought Leader Liaisons Within the Multiple Sclerosis Space
Nov 14, 2018
Pharmaceutical Companies are Introducing More Immunology Products into the Market, Causing an Expansion in Competition Around the Globe
Oct 30, 2018
U.S. Pharmaceutical Companies Have Moved Vaccine Sales Forces Toward a More Specialized Approach, According to PharmaForce International
Oct 23, 2018
PharmaForce International: U.S. Pharmaceutical Companies Move Toward Utilization of Tracking Platforms for Medical Science Liaison Deployment
Oct 11, 2018
PharmaForce International: Research Indicates Increased Presence of Medical Support Personnel in the Oncology/Hematology Space Across All Regions
Feb 13, 2018
PharmaForce International: Research Indicates Continued Migration Toward Specialty Oncology Sales Forces and Novel Breakthrough Medical Therapy Options for Cancer Patients
Dec 05, 2017
PharmaForce International: Hemophilia Companies are Increasing Efforts to Target Specialized Physicians
Aug 01, 2017
PharmaForce International: Majority of Physicians Say They Feel "Somewhat" or "Very" Comfortable in Prescribing a Biosimilar in Place of a Traditional Biologic